{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/typhoid-fever/","result":{"pageContext":{"chapter":{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever","depth":2,"htmlHeader":"<!-- begin field c4aa65aa-7f88-406f-b7e3-3dbd71d32dba --><h2>Scenario: Typhoid fever</h2><!-- end field c4aa65aa-7f88-406f-b7e3-3dbd71d32dba -->","summary":"Covers advice for people travelling to areas endemic with typhoid fever.","htmlStringContent":"<!-- begin item f1832c1b-b59d-4579-bbf0-919b08661bb9 --><!-- begin field aa84b89f-9c04-467f-80e6-acd900ab524a --><p>From age 18 months onwards.</p><!-- end field aa84b89f-9c04-467f-80e6-acd900ab524a --><!-- end item f1832c1b-b59d-4579-bbf0-919b08661bb9 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"45507f29-9e4a-5314-b957-348a6196619a","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field 60b91e6d-b6dc-4130-9a2b-7818053469e4 --><h3>Indications for vaccine</h3><!-- end field 60b91e6d-b6dc-4130-9a2b-7818053469e4 -->","summary":null,"htmlStringContent":"<!-- begin item 76a1d286-361a-4030-9d5c-5c908be0408d --><!-- begin field cdab72e6-0ca6-4abf-bbb1-ecf23a5bf8b0 --><ul><li><strong>Give a typhoid vaccination to travellers to countries where typhoid is endemic (for detailed information, see the <a href=\"http://www.nathnac.org/\" data-hyperlink-id=\"e2807d59-47f3-41ff-a57f-a93100c55ace\">NaTHNaC</a> website), especially if they are:</strong><ul><li>Staying with or visiting the local population.</li><li>Likely to experience frequent and/or prolonged exposure to conditions where sanitation and food hygiene are poor.</li></ul></li><li>Note: the person should be advised that not all recipients of typhoid vaccines will be protected against typhoid fever, and the vaccine does not protect against paratyphoid infection. They should therefore take all necessary precautions to avoid contact with, or ingestion of, potentially contaminated food or water.</li></ul><!-- end field cdab72e6-0ca6-4abf-bbb1-ecf23a5bf8b0 --><!-- end item 76a1d286-361a-4030-9d5c-5c908be0408d -->","subChapters":[{"id":"f6ca5b8b-6896-5e1e-a52d-b82c447c8135","slug":"basis-for-recommendation-2fe","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 25fce1b9-f5dd-4814-be23-4ec7c4b626d0 --><h4>Basis for recommendation</h4><!-- end field 25fce1b9-f5dd-4814-be23-4ec7c4b626d0 -->","summary":null,"htmlStringContent":"<!-- begin item 2fece3c8-1e21-4431-aa6d-8399de707595 --><!-- begin field c2577626-c2cf-4fb3-833b-7d07f841179e --><p>The recommendations on indications for typhoid vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 33: Typhoid</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>].</p><!-- end field c2577626-c2cf-4fb3-833b-7d07f841179e --><!-- end item 2fece3c8-1e21-4431-aa6d-8399de707595 -->","subChapters":[]}]},{"id":"baf9b5ba-7d59-507c-9b83-4f8c614fd2c5","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field e151aa4e-196c-46f8-bf8b-8cc2a10720f3 --><h3>Available vaccines and vaccination schedules</h3><!-- end field e151aa4e-196c-46f8-bf8b-8cc2a10720f3 -->","summary":null,"htmlStringContent":"<!-- begin item c1b94ca4-9352-4884-8e6a-38e91ec4fd3d --><!-- begin field f019a213-d643-4a02-b61d-274f2e0413e5 --><ul><li><strong>Several vaccines are available that offer protection against typhoid fever:</strong><ul><li>The inactive capsular polysaccharide typhoid vaccine (Typhim Vi<sup>®</sup>) contains purified Vi capsular polysaccharide from <em>Salmonella typhi </em>organisms.</li><li>An inactivated combined vaccine for hepatitis A and typhoid fever (ViATIM<sup>®</sup>) is also available and may be useful for people requiring simultaneous coverage against both illnesses.<ul><li>Maximum antibody response to inactivated typhoid vaccine is achieved 1 month following vaccination and persists for about 3 years.</li></ul></li><li>A live (oral) typhoid vaccine containing a live attenuated strain of <em>S. typhi </em>Ty21a in an enteric capsule (Vivotif<sup>®</sup>) is also available.<ul><li>Protection commences about 7–10 days after completion of a three-dose course of live oral typhoid vaccine.</li></ul></li></ul></li></ul><p><strong>Table 5</strong><strong>. </strong>Schedule for typhoid vaccination.</p><table data-table-id=\"ba07b5ea-f6e7-427c-8df8-acce014c1ca6\"><thead><tr><th><p>Vaccine</p></th><th><p>Schedule</p></th><th><p>Length of protection</p></th><th><p>Age</p></th></tr></thead><tbody><tr><td>Typhim Vi<sup>®</sup></td><td>Single dose.</td><td>Booster doses required at 3 yearly intervals for people who remain at risk.</td><td>From 2 years*.</td></tr><tr><td>ViATIM<sup>®</sup> (combined hepatitis A and typhoid vaccine)</td><td>Single dose of combined vaccine.</td><td>Typhoid re-vaccination with single dose of purified polysaccharide typhoid vaccine required every 3 years. Hepatitis A booster dose of inactivated hepatitis A vaccine required after 6–12 months.</td><td>From 16 years.</td></tr><tr><td><p>Vivotif<sup>®</sup></p></td><td>Three capsules on days 0, 2, and 4.</td><td>Three-dose booster course required at 3 yearly intervals for people who remain at risk.</td><td>From 5 years.</td></tr><tr><td colspan=\"4\">*Children between the ages of 12 months and 2 years should be immunized if the risk of typhoid fever is considered high. Immunization is not recommended for children under 1 year of age.</td></tr></tbody></table><!-- end field f019a213-d643-4a02-b61d-274f2e0413e5 --><!-- end item c1b94ca4-9352-4884-8e6a-38e91ec4fd3d -->","subChapters":[{"id":"9720868d-153f-5ba7-9a28-058c921fe8f8","slug":"basis-for-recommendation-a7a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 20c61a29-46bc-483b-a352-8e2cfcf1aaac --><h4>Basis for recommendation</h4><!-- end field 20c61a29-46bc-483b-a352-8e2cfcf1aaac -->","summary":null,"htmlStringContent":"<!-- begin item a7af4ac4-d8b0-45f2-94b2-981d56056ad9 --><!-- begin field 938514d6-2741-49f3-bc3d-431f74cc891e --><p>The information on available types of typhoid vaccine and vaccination schedules is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 33: Typhoid</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>].</p><!-- end field 938514d6-2741-49f3-bc3d-431f74cc891e --><!-- end item a7af4ac4-d8b0-45f2-94b2-981d56056ad9 -->","subChapters":[]}]},{"id":"fecc6ed1-4214-53bf-a549-95b5acc6e91b","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 9b9c31c1-18ab-471f-90bd-280a0428b8f8 --><h3>Contraindications to vaccine</h3><!-- end field 9b9c31c1-18ab-471f-90bd-280a0428b8f8 -->","summary":null,"htmlStringContent":"<!-- begin item 997ebcc0-32ca-4507-b95c-c37157de59c9 --><!-- begin field 11ec2396-d39f-4f60-8baa-62ae8162c39a --><ul><li><strong>Typhoid Vi vaccine should not be given to people who have had:</strong><ul><li>A confirmed anaphylactic reaction to a Vi-antigen-containing vaccine.<ul><li>Severe reactions to a previous dose of non-Vi typhoid vaccine do <em>not</em> contraindicate the subsequent use of a Vi vaccine.</li></ul></li></ul></li><li><strong>Ty21a vaccine should not be given to those who:</strong><ul><li>Are immunosuppressed.</li><li>Have had a confirmed anaphylactic reaction to any component of the Ty21a vaccine or enteric-coated capsule, including gelatin.</li></ul></li><li><strong>Postpone typhoid vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>In the event of a gastrointestinal illness, vaccination with the Ty21a vaccine should be postponed until after recovery. </strong></li><li><strong>Ty21a vaccine should not be commenced within 3 days of completing any antibacterial agents,</strong> and antibacterial therapy should not commence within 3 days after the last dose of vaccine.</li><li><strong>Typhoid vaccine may be given to pregnant women if the risk of typhoid is high.</strong> The inactivated Vi vaccine may be preferred in pregnancy. There is no evidence of risk from vaccinating pregnant women or those who are breastfeeding with inactivated virus, bacterial vaccines, or toxoids.</li></ul><!-- end field 11ec2396-d39f-4f60-8baa-62ae8162c39a --><!-- end item 997ebcc0-32ca-4507-b95c-c37157de59c9 -->","subChapters":[{"id":"70e3c661-611f-56b8-a975-f6427b758304","slug":"basis-for-recommendation-788","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a6012ddb-e320-47b4-b16a-bfd074abd5d0 --><h4>Basis for recommendation</h4><!-- end field a6012ddb-e320-47b4-b16a-bfd074abd5d0 -->","summary":null,"htmlStringContent":"<!-- begin item 788819b3-35e1-4903-8b35-4e61171e201a --><!-- begin field e5fd69b5-e337-4cb4-877f-2d28d696cf52 --><p>The information on contraindications to typhoid vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 33: Typhoid</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>] and<em> Chapter 6: Contraindications and special considerations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><h5>Use of inactivated Vi vaccine in pregnancy</h5><ul><li>The inactivated Vi vaccine is preferred in pregnancy due to the theoretical risk of fetal infection from use of live vaccines. However, Public Health England recommends that where the risk of typhoid is high, use of a live vaccine should be considered if there is no alternative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>]. </li></ul><!-- end field e5fd69b5-e337-4cb4-877f-2d28d696cf52 --><!-- end item 788819b3-35e1-4903-8b35-4e61171e201a -->","subChapters":[]}]},{"id":"8c73eede-4421-5c1e-a13a-bed679a4c1d4","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 1cc1fd65-9ae1-489f-9225-eecfba27a124 --><h3>Adverse effects</h3><!-- end field 1cc1fd65-9ae1-489f-9225-eecfba27a124 -->","summary":null,"htmlStringContent":"<!-- begin item c5347890-db2e-4328-8eb7-67093441e9bc --><!-- begin field fb81d77c-42fb-47a0-8b65-c480fc13c409 --><ul><li><strong>Vi vaccine:</strong><ul><li>Local reactions (pain, swelling, erythema, and induration at injection site) are the most commonly reported symptoms following Vi vaccine. These symptoms are usually mild and transient.</li><li>Systemic reactions following the vaccine are infrequent. Fever occurs in about 1% of vaccine recipients. Headache, nausea, diarrhoea, and abdominal pain have been reported but are uncommon.</li><li>There have been rare reports of anaphylaxis following administration of Vi vaccine.</li></ul></li><li><strong>Ty21a vaccine:</strong><ul><li>The most commonly reported adverse events are gastrointestinal symptoms, fever, influenza-like symptoms, and headache.</li></ul></li></ul><!-- end field fb81d77c-42fb-47a0-8b65-c480fc13c409 --><!-- end item c5347890-db2e-4328-8eb7-67093441e9bc -->","subChapters":[{"id":"24bed728-3a6a-59b6-b6c0-aa6da9379f2b","slug":"basis-for-recommendation-df8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9c340aef-19db-4fea-9a24-24270a0a6d12 --><h4>Basis for recommendation</h4><!-- end field 9c340aef-19db-4fea-9a24-24270a0a6d12 -->","summary":null,"htmlStringContent":"<!-- begin item df8d8b72-61e4-42f4-98a8-ba23c6008d56 --><!-- begin field fd974949-b110-4cc7-9bd6-ba1fcbe56323 --><p>The information on adverse effects of typhoid vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 33: Typhoid</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>].</p><!-- end field fd974949-b110-4cc7-9bd6-ba1fcbe56323 --><!-- end item df8d8b72-61e4-42f4-98a8-ba23c6008d56 -->","subChapters":[]}]},{"id":"57e8a50c-6f51-5b3c-b137-233d831bd2f6","slug":"how-to-administer-typhoid-vaccine","fullItemName":"How to administer typhoid vaccine","depth":3,"htmlHeader":"<!-- begin field 4d33e2fc-0117-4256-9a23-110b14511bd3 --><h3>How to administer typhoid vaccine</h3><!-- end field 4d33e2fc-0117-4256-9a23-110b14511bd3 -->","summary":null,"htmlStringContent":"<!-- begin item b0da214a-7e23-4421-a1c9-bd4d2c98b543 --><!-- begin field 22f18342-9438-4e4e-ade4-444e6c9e1afb --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/typhoid-fever/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/typhoid-fever/#adverse-effects\">adverse reactions</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li><li>The vaccination site has been washed with soap and water if it is visibly dirty (if applicable). </li></ul></li><li><strong>Typhoid vaccine can be given by intramuscular (IM) injection or taken orally.</strong><ul><li><strong>Injections should be given</strong><strong> into the upper arm in children over 1 year of age and adults.</strong> However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Capsules should be taken about 1 hour before a meal with a cold or lukewarm drink</strong> (temperature not to exceed 37°C). The vaccine capsule should not be chewed and should be swallowed as soon as possible after placing in the mouth.</li></ul></li><li><strong>Typhoid vaccine can be given at the same time as other vaccines.</strong> If an additional injected vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 22f18342-9438-4e4e-ade4-444e6c9e1afb --><!-- end item b0da214a-7e23-4421-a1c9-bd4d2c98b543 -->","subChapters":[{"id":"a1de0813-d753-5cc9-b531-890134975a3e","slug":"basis-for-recommendation-168","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c89a3bda-c0eb-4d69-8983-9725d6d2628b --><h4>Basis for recommendation</h4><!-- end field c89a3bda-c0eb-4d69-8983-9725d6d2628b -->","summary":null,"htmlStringContent":"<!-- begin item 16861538-2a82-4fa8-9b7a-6c6dc4438bea --><!-- begin field 90a8ee1e-9881-481f-82e0-6f9950c1ed43 --><p>The recommendations on administering typhoid vaccine are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 33: Typhoid</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020b</a>], <em>Chapter 2: Consent</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><div><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul></div><!-- end field 90a8ee1e-9881-481f-82e0-6f9950c1ed43 --><!-- end item 16861538-2a82-4fa8-9b7a-6c6dc4438bea -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}